Pralmorelin dihydrochloride

N/A

Report date: 2022/05/18 16:21:19
NME

Base Information

Drug NamePralmorelin dihydrochloride
Drug Alias Name普拉莫瑞林Pralmorelin hydrochlorideGrowth hormone releasing peptide 2GHRP Kaken 100KP-102D +[11] 
ClassificationSmall molecules > Heterocyclic drugsDiagnostic agent (In vivo)
Mechanisms of ActionGhrelin/growth hormone secretagogue receptor agonists
TargetsGhrelin/growth hormone secretagogue receptor
Therapy Area/IndicationsGrowth hormone deficiencyDiagnostic agents
Global Approved IndicationsGrowth hormone deficiencyDiagnostic agents
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date2004/10/22
Country/TerritoryJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesTulane UniversityPolygen Pharmaceuticals Llc
China Registration ClassN/A

Develop Information

Active CompaniesKaken Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsGrowth hormone deficiencyDiagnostic agents
Inactive IndicationsN/A

Other Information

ATC CodeV04CX
Related LinksWikipediaKEGG